Therefore, obesity or T2DM models, effective inhibition of NLRP3 inflammasome activation reduces the inflammatory response of β cells, thereby improving insulin sensitivity by inhibiting the production of IL-1β. This evidence concerns the gene IL1B and type 2 diabetes mellitus.